Trial · NCT00784134
Registered outcomes46
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 46
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Participants With Modified Rankin Scale (mRS) <=3 - Dichotomized Analysis | 180 days | Analysis modified on September 29, 2015 to account for adaptive randomization. The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death). |
| Primary | Participant Score on the Modified Rankin Scale (mRS) - Ordinal Analysis | 180 days | The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death). |
| Primary | Participants With Modified Rankin Scale (mRS) <=4 - Dichotomized Analysis | 180 days | The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death). |
| Primary | Random Effects Assessment of Site Effect on Modified Rankin Scale (mRS) <= 3 | 180 days | The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death). |
| Primary | Longitudinal Assessment of Participants With Modified Rankin Scale (mRS) <=3 | 30 days and 180 days | Comparing longitudinal modified Rankin Scale (mRS) scores 0-3 at Day 30 and Day 180. The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is scored from 0 (perfect health without symptoms) to 6 (death). |
| Secondary | All Cause Mortality | 180 days | |
| Secondary | Clot Removal (Amount of Residual Blood) | 72 hours | Change in blood volume measured between stability scan and end of treatment scan |
| Secondary | Intensity of Critical Care Management - Hospital Days | 30 days | Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections. |
| Secondary | Intensity of Critical Care Management - ICU Days | 30 days | Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections. |
| Secondary | Intensity of Critical Care Management - ICP Management | 30 days | Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections. |
| Secondary | Intensity of Critical Care Management - Mechanical Ventilation | 30 days | Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections. |
| Secondary | Intensity of Critical Care Management - Pressors | 30 days | Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections. |
| Secondary | Intensity of Critical Care Management - Shunts | 30 days | Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections. |
| Secondary | Intensity of Critical Care Management - All Infections | 30 days | Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections. |
| Secondary | Intensity of Critical Care Management - Pneumonia | 30 days | Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections. |
| Secondary | Intensity of Critical Care Management - All Infections | 180 days | Intensity of critical care management as measured by hospital and ICU length of stay, frequency of ICP \>20 mmHg events, use of mechanical ventilation, pressors, and ventriculoperitioneal shunts, frequency of systemic infections. |
| Secondary | Safety/Mortality - Mortality Within 30 Days | 30 days | Frequency of bacterial brain infections, symptomatic brain bleeds, and mortality. |
| Secondary | Safety/Mortality - Bacterial Brain Infections Within 30 Days | 30 days | Frequency of bacterial brain infections, symptomatic brain bleeds, and mortality. |
| Secondary | Safety/Mortality - Systematic Bleeds Within 72 Hours | 72 hours | Frequency of bacterial brain infections, symptomatic brain bleeds, and mortality. |
| Secondary | Safety/Mortality - Systematic Bleeds Within 30 Days | 30 days | Frequency of bacterial brain infections, symptomatic brain bleeds, and mortality. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00784134/registered